FR
Menu
Insights

SPUR™ Phase 0 study: final results

To access the SPUR™ research website, click here

If you ever wanted to better understand the behavioral concepts behind the SPUR model, we invite you to read this fascinating publication!

 

Objective

The objective was to examine existing frameworks from medicine, psychology, sociology, consumer behavior, and economics to elaborate a comprehensive, quantitative profiling approach that can be used to drive the customization of patient support initiatives through digital support.

Methodology

Extensive literature review by a board of scientific experts led to the elaboration of a decision-making framework.

Building primarily on the Theory of Planned Behavior (TPB), the Health Belief Model (HBM) was used to inform the beliefs about behavior posited in the TPB, while incorporating established factors regarding self-efficacy in the “control” elements of the TPB and selected social and psychological factors in the other constituents of the model.

The resulting model is specific to behaviors regarding chronic diseases and takes into account a number of established frameworks that have been demonstrated to influence adherence behavior.

Shcema-SPUR-MAJ-ConvertImage.jpg

Conclusion

The SPUR (Social, Psychological, Usage, Rational) framework represents a holistic, profiling tool with detailed, quantitative outputs that describe a patient’s behavioral risks and the drivers of that risk.

SPUR 4 categories

An interactive, digital questionnaire built around SPUR represents a potentially useful tool for those desirous of building interactive digital support programs for patients with chronic diseases.

The next step is to build a questionnaire based on the SPUR framework and test its predictive validity. We are carrying out such a study across a range of pathologies. Learn more about our research program.

Read the publication

Share

See also

Scientific communications

A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool

Articles

Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials

News

By your side in 2024: Happy Holidays from Observia!

Accès plateformes